Clinical trials

Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.

7,113 studies match

clinicaltrialsPublishedShowing 101–150 of 7,113 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04181060	Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer	recruiting	Phase 3	300	National Cancer Institute (NCI)NIH	1	Sep 29, 2026	clinicaltrials
NCT04616560	Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor	recruiting	Phase 2	55	National Cancer Institute (NCI)NIH	1	Sep 29, 2026